Epidemiology,Virology and Pathogenesis of Viral Hepatitis with a Focus on Latin America

Perz J.F. , Armstrong G.L. , Farrington L.A. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529–538.

WHO Executive Board. Viral hepatitis: report by the Secretariat, EB126/15. Geneva: World Health Organization 2009.

World Health Organization. Prevention and control of viral hepatitis infection: framework for global action. (Updated 23 July 2012. Accessed 14 June 2012.) Available from http://www.who.int/csr/disease/hepatitis/Framework/en/index.html.

Alvarado-Mora M.V. , Rebello Pinho J.R. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther 2013; 18: 429–433.

Lampe E. , Lewis-Ximenez L. , Espírito-Santo M.P. Genetic diversity of HCV in Brazil. Antivir Ther 2013; 18: 435–444.

Kikuchi L. , Chagas A.L. , Alencar R.S.S.M. , Paranaguá-Vezozzo D.C. , Carrilho F.J. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Antivir Ther 2013; 18: 445–449.

Núñez M. , Mendes-Correa M.C. Viral hepatitis and HIV: update and management. Antivir Ther 2013; 18: 451–458.

Alvarado-Mora M.V. , Rebello Pinho J.R. Distribution of HBV genotypes in Latin America. Antivir Ther 2013; 18: 459–465.

Osiowy C. , Simons B.C. , Rempel J.D. Distribution of viral hepatitis in indigenous populations of North America and the circumpolar Arctic. Antivir Ther 2013; 18: 467–473.

Panduro A. , Maldonado-Gonzalez M. , Fierro N.A. , Roman S. Distribution of HBV genotypes F and H in Mexico and Central America. Antivir Ther 2013; 18: 475–484.

Marciano S. , Galdame O.A. , Gadano A.C. HBV genotype F: natural history and treatment. Antivir Ther 2013; 18: 485–488.

Simmonds P. , Midgley S. Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 2005; 79: 15467–15476.

Mulders M.N. , Venard V. , Njayou M. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004; 190: 400–408.

Fares M.A. , Holmes E.C. A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 2002; 54: 807–814.

Tedder R.S. , Bissett S.L. , Myers R. , Ijaz S. The ‘Red Queen’ dilemma – running to stay in the same place: refections on the evolutionary vector of HBV in humans. Antivir Ther 2013; 18: 489–496.

Bouckaert R. , Alvarado-Mora M.V. , Rebello Pinho J.R. Evolutionary rates and HBV: issues of rate estimation with Bayesian molecular methods. Antivir Ther 2013; 18: 497–503.

Godoy B.A. , Alvarado-Mora M.V. , Gomes-Gouvêa M.S. , Rebello Pinho J.R. , Fagundes N.J.R. Origin of HBV and its arrival in the Americas – the importance of natural selection on time estimates. Antivir Ther 2013; 18: 505–512.

Kramvis A. , Paraskevis D. Subgenotype A1 of HBV – tracing human migrations in and out of Africa. Antivir Ther 2013; 18: 513–521.

Taylor D.R. Evolution of cell culture systems for HCV. Antivir Ther 2013; 18: 523–530.

Moriconi F. , Beard M.R. , Yuen L.K.W. Bioinformatics methods for the analysis of hepatitis viruses. Antivir Ther 2013; 18: 531–539.

Alvarado-Mora M.V. , Locarnini S. , Rizzetto M. , Rebello Pinho J.R. An update on HDV: virology, pathogenesis and treatment. Antivir Ther 2013; 18: 541–548.